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1. Introduction
Infectious diseases, particularly zoonoses, are recognized as the sources of serious problems
that affect public and animal health around the world. Emerging infectious diseases have been
reported at an unprecedented rate since the 1970s and a large proportion of these diseases are
considered to be zoonoses [1]. However, reemerging zoonoses are also affecting public health
around the world, in particular rabies, a classic zoonosis that is problematic in Africa and Asia,
while new outbreaks have occurred in areas that were previously free of this disease, such as
the islands of Flores and Bali in Indonesia [2].
Thus, research and technology development have been promoted for controlling emerging
and reemerging zoonoses in developed countries. In the case of rabies, the research and
technology developed to prevent this disease has been advancing. Rabies is a vaccine-
preventable disease, so a vaccine has been developed. The type of vaccine produced using
animal nervous tissues has been progressively replaced by safer and more immunogenic
vaccines, which are purified from cell culture supernatants. In addition, new replicative
vaccines have been developed for the oral vaccination of wildlife, which are either attenuated
rabies vaccines or recombinant vaccines where different viruses express the rabies glycopro‐
tein [3]. Moreover, user-friendly diagnostic methods have been developed, e.g., a rapid
immunochromatographic test kit and a simple enzyme-linked immunosorbent assay (ELISA)
[4,5]. Understanding the current trends in research and technology development related to
rabies control may provide a useful reference regarding the technological needs encountered
in the field of zoonoses.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Bibliometric analysis is considered to be an effective method for identifying research trends in
infectious disease control. Quantitative surveys of research articles (hereafter referred to as
article) based on bibliometric studies have been reported in the field of infectious diseases,
such as human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)
[6], tuberculosis research in India and China [7], and various forms of infectious disease
research in different regions of the world [8], Asia [9], and around the world [10]. In particular,
we have surveyed Asian and worldwide research trends, while ensuring that we avoided
underestimating the number of articles in non-English and regional journals, rather than
simply surveying journals registered in the “Infectious Disease Category” of the Science
Citation Index ExpandedTM [9,10].
Patent analysis is also considered to be an effective method for technology development trend
analysis. Patents are examined and granted by patent offices, and they are considered to be
objective indicators of technology development activities. In addition, patents have significant
advantages in terms of database availability, the variety of information included, and their
systematic classification according to standardized schemes, e.g., the international patent
classification (IPC) supports the detailed analysis of specific technological aspects. For these
reasons, patent data are used intensively for strategic technology management by companies
[11], as well as for science and technology (S&T) measurement in policy-making processes and
academic research in various fields [12]. Indeed, patent analyses have been reported in the
field of infectious diseases, such as hepatitis B vaccines [13] and influenza [14,15].
Research and technology development for rabies control is considered to be important for
future public and animal health throughout the world, as described above. However, to the
best of our knowledge, bibliometric and patent analyses of rabies have not been reported yet.
Therefore, in this chapter, we report the current trends in research and technology develop‐
ment for rabies control in the US, the EU, and Asia based on analyses of articles and patent
applications. We targeted patent applications because publication of a patent application is
invariably the earliest point when relevant technology information becomes available to the
public because it is the first set of detailed and up-to-date published information. Furthermore,
the number of patent applications in particular technological areas is considered to indicate
the volume of resources allocated [16].
The trends in research and technology development for rabies control will be summarized
using the following indicators.
• Number of articles and patent applications during each year and by each country
• Number of authors and applicants by nationality
• Number of articles by organization
• Major research areas of articles and the technical areas of patent applications
• Top 10 cited articles and patent applications
Based on this analysis, we discuss the future directions of research and technology develop‐
ment for rabies control. Moreover, we propose the development of a survey method for
zoonosis control, research and technology development.
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2. Trends in rabies research based on articles
We used a two-tiered approach to analyze research related to rabies control. First, we per‐
formed a quantitative analysis of all articles about rabies. Subsequently, we analyzed the top
10 cited articles, irrespective of whether they were related to rabies control.
2.1. Method of analysis
The Web of Science® [17] was used to survey articles about rabies, which covers over 12,000
journals worldwide, including open access journals. Using the Web of Science®, keyword and
title search of articles was performed using the terms “Rabies” OR “Lyssa” (to include virus
species related to rabies virus) NOT “Rabi” (to exclude articles in the field of optics, e.g., articles
related to “Rabi oscillations”) on June 24, 2013. The publication period of articles ranged from
January 1, 2001 to December 31, 2011.
We focused on articles and excluded reviews, proceedings papers, and other types of publi‐
cations. This is because articles are high quality because they have been peer reviewed and are
directly linked to the outputs of the latest research.
Other articles in the field of infectious diseases retrieved by the Web of Science® were also
analyzed to identify the characteristics of articles related to rabies.
2.2. Leading countries based on the number of articles
The total number of articles related to rabies published throughout the world during 2001–
2011 was 2,565. We regrouped the articles by country to identify any possible differences in
research output among countries. The US was the leading country, with the highest percentage
of total articles, i.e., 32.5% of the total (833 articles). There was a big gap for the second placed
country, France, with 10.6% of the total (273 articles). The UK, Brazil, and Germany followed
with 10.1% (258 articles), 8.6% (220 articles), and 7.2% (185 articles), respectively (Figure 1).
As shown in Table 1, the US, France, the UK, and Germany were the top four countries with
most articles related to rabies, and they were also the leading countries for all articles about
infectious diseases. However, Brazil ranked in the top five with most articles related to rabies.
This showed that rabies research was a particular focus in Brazil.
2.3. Annual changes in the number of articles
As shown in Figure 2, the total number of articles related to rabies increased during 2001–2011.
However, the US did not show a remarkable change, although it produced the highest output.
Other countries such as the UK, France, Brazil, and Germany also had stable outputs. Thus,
the overall increase in articles was considered to be attributable to other countries that were
not surveyed in this study.
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Figure 1. Number of articles related to rabies by country during 2001–2011
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Rank Country Number of
articles
Relative to 
the total 
number of 
articles (%)
1 US 833 32.5
2 France 273 10.6
3 UK 258 10.1
4 Brazil 220 8.6
5 Germany 185 7.2
Number of articles about rabies
Rank Country Number of
articles
Relative to 
the total
number of 
articles (%)
1 US 35,488 38.5
2 UK 9,437 10.2
3 France 7,625 8.3
4 Germany 4,908 5.3
5 Spain 4,906 5.3
Number of articles in the field of
infectious diseases
Search condition
Research field: infectious diseases
Document type: Article 
Total number of articles: 92,113 articles
Search condition
Keywords: Rabies OR Lyssa NOT Rabi
Document type: Article 
Total number of articles: 2,565 articles
Table 1. Comparison of the rankings for articles related to rabies and all infectious disease articles during 2001–2011
2.4. Number of articles by organization
US Centers for Disease Control and Prevention (US CDC) published most articles related to
rabies (198 articles) during 2001–2011. Institut Pasteur (France) and Thomas Jefferson Univer‐
sity (US) published the second and third highest numbers of articles (141 and 87 articles,
respectively) (Figure 3).
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Figure 2. Number of articles related to rabies by year during 2001–2011
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Figure 3. Number of articles related to rabies by organization during 2001–2011
2.5. Major research areas
Figure 4 shows the number of articles related to rabies for each research field, which showed
that the main field of rabies research was veterinary sciences. Research was also conducted in
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basic sciences, such as virology and immunology. It is considered that virological and
immunological research on rabies contributes to the development of vaccines and diagnostic
methods.
Veterinary sciences
Virology
Immunology
Infectious diseases
research experimental
medicine
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427410
305 237
The values are the number of articles.
Figure 4. Number of articles related to rabies by research field during 2001–2011
2.6. Top 10 cited articles
Table 2 shows top 10 most cited articles related to rabies. Of these articles, two reported and
discussed methods for rabies control [18,19]. It was interesting that the two articles were based
on new research areas, i.e., agent-based modeling and economic analysis. These studies were
not categorized in the major research areas described in Section 2.5.
Three articles reported rabies virus as the delivery of a substance to the brain, i.e., a neuronal
tracer, and a vector [20–22]. This shows that research on rabies may contribute to neuroscience
research.
3. Trends in technology development related to rabies control based on
patent applications
Subsequently, we performed quantitative and qualitative analyzes of patent applications
related to rabies control, e.g., technologies related to vaccines, screening, and the diagnosis of
rabies.
3.1. Method of analysis
The survey of patent applications comprised the following four steps.
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Rank Cited
number
Title Author(s) Journal Volume, Page, Year Contribution  to rabies 
control
1 400 Pattern-oriented modeling of agent-based 
complex systems: Lessons from ecology
Grimm, V. 
et al.,
SCIENCE 310, 987–991, 2005 Yes (rabies prevalence 
simulation )
2 377 Transvascular delivery of small interfering 
RNA to the central nervous system
Kumar, P. et al., NATURE 448, 39–43, 2007 No (usage of viral peptide 
as delivery to the brain)
3 339 Cerebellar loops with motor cortex and 
prefrontal cortex of a nonhuman primate
Kelly, R.M. et al., JOURNAL OF 
NEUROSCIENCE
23, 8432–8444, 2003 No (usage of virus as 
neuronal tracer)
4 314 Efficacy of RTS,S/ASO2 malaria vaccine 
against Plasmodium falciparum infection in 
semi-immune adult men in The Gambia: a 
randomised trial
Bojang, K.A. et al., LANCET 358, 1927–1934, 2001 No (usage of rabies vaccine 
as a control of malaria 
vaccine)
5 288 Re-evaluating the burden of rabies in Africa 
and Asia
Knobel, D.L. et al., BULLETIN OF THE 
WORLD HEALTH 
ORGANIZATION 
83, 360–368, 2005 Yes (study to quantify 
public health and economic 
burden)
6 261 Small world effect in an epidemiological mode Kuperman, M. et al., PHYSICAL REVIEW 
LETTERS
86, 2909–2912, 2001 No (epidemiological model 
based on the structure of a 
population)
7 249 Cannabinoid-based drugs as anti-
inflammatory therapeutics
Klein, T.W. NATURE REVIEWS 
IMMUNOLOGY
5, 400–411, 2005 No (therapeutic usefulness 
of these drugs in chronic 
inflammatory diseases)
8 239 Diseases of humans and their domestic 
mammals: pathogen characteristics, host range 
and the risk of emergence
Cleaveland, S. et al., PHILOSOPHICAL 
TRANSACTIONS OF 
THE ROYAL SOCIETY 
OF LONDON SERIES 
B-BIOLOGICAL 
SCIENCES
356, 991–999, 2001 Indirectly yes (database 
analysis of multihost
pathogens)
9 214 Rabies virus glycoprotein pseudotyping of 
lentiviral vectors enables retrograde axonal 
transport and access to the nervous system 
after peripheral delivery
Mazarakis, N,D. et al., HUMAN 
MOLECULAR 
GENETICS
10, 2109–2121, 2001 No (usage of virus protein 
as a virus vector)
10 208 Population biology of multihost pathogens Woolhouse, M.E.J. 
et al.,
SCIENCE 292, 1109–1112, 2001 Indirectly yes (database 
analysis of multihost
pathogens)
Table 2. Top 10 cited articles related to rabies during 2001–2011
3.1.1. Step 1-Collection of data sources for patent applications
The Derwent Patent Index® (DWPI) and the Derwent Patent Citation Index® (DPCI) [23,24]
were used to survey patent applications related to rabies control using the search strategy
described below.
DWPI is one of the largest and most user-friendly patent databases in the world, which contains
over 21.85 million patent families that cover over 45.2 million patent documents. It includes
coverage of over 47 worldwide patent authorities with enhanced patent titles and abstracts
prepared by subject experts to facilitate the survey of patent documents. Additionally the
DWPI assembles all of the patent documents relating to an invention into a single database
record as a "patent family". A single "patent family" is a set of either patent applications or
publications taken in multiple countries to protect a single invention by a common inventor(s)
[25]. DPCI provides patent citation information from 10 organizations, including the EPO and
the WIPO.
To survey the number of applicants by nationality, we used the FAMPAT® [26], which is a
comprehensive worldwide patent family database. We used the FAMPAT® because the DWPI
does not include the nationalities of applicants.
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3.1.2. Step 2-Screening and selection of patent applications
Using the DWPI, we surveyed Asian, US, and European patent applications related to rabies
control by patent family, as well as patent applications filed under the International Patent
Cooperation Treaty [27] for 2001–2011 (the year when priority was claimed based on the patent
application) on December 21, 2012. In this study, one should note that the data of ”patent
applications” represented the data of ”patent families” assembled uniquely by the DWPI. The
countries targeted for analysis are shown in Table 3 and they were selected based on our
previous study, i.e., the countries that published more infectious disease research articles than
other countries [10].
We screened patent applications using search formulae 1–7 as shown in Table 3, which were
based on keywords and the IPC. Patent applications were selected that contained the keywords
in the titles or abstracts and that belonged to the IPC categories. To ensure the complete capture
of all relevant patent applications, we used “Rabies” and inflected forms of the keywords such
as “Rabic” and “Rabid”, and “Lyssa.” We also used the IPC categories that included antigens,
antibodies, amino acids, chemical compounds, and anti-infectives related to the Rhabdoviri‐
dae family or RNA viruses, which include the rabies virus and lyssaviruses.
After screening the patent applications, we selected patent applications related to rabies
control. We reviewed all the abstracts and claims for patent applications to identify applica‐
tions related to the prevention and diagnosis of rabies.
We primarily focused on patent applications that claimed technologies for preventive and
diagnostic uses related to rabies genes and proteins, but we also included applications related
to technologies for producing vaccine adjuvants and for stabilization, as well as other pertinent
items within the search scope. For example, a patent application was included that claimed a
recombinant adenovirus as a rabies vaccine carrier. However, we excluded patent applications
related to research and therapeutic tools for other diseases, e.g., the synthesis of rabies virus
proteins for human neurodegenerative disorder therapy and the development of a rabies virus
vector for expressing other viral proteins.
3.1.3. Step 3-Analysis of patent applications
The patent applications selected in Step 2 were analyzed with respect to the following items;
patenting activity (the number of patent applications per application year and for each country,
and the number of applicants by nationality), major technical areas of patent applications, and
the most cited patent applications. We used citation analysis as an indicator of important
technological progress, upon which many later patents may rely [28].
3.2. Total number of patent applications
The screening of patent applications related to rabies control retrieved 354 candidates. The
candidates included keywords related to rabies in the titles or abstracts and belonged to the
IPC categories A61K-039/205, C07K-014/145, A61P-031/12, A61P-031/14, or G01N-033/569
(Table 3). Subsequently, we selected 237 of 354 patent applications by reviewing all the
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abstracts and claims to identify patent applications related to rabies control. The following
analysis was based on results, which included 237 patent applications.
3.3. Annual change in the number of patent applications by country
We regrouped the patent applications and applicants for each country to identify possible
differences in technology development among various countries. The numbers of PCT
applications and applications in each country were stable during 2001–2011, except in China
where the number increased relatively. The US had the most patent applications until 2007,
but was overtaken by China in 2008. We found that China had a remarkable increase in patent
Search formula Number of
patent
applications
retrieved*
Survey content
1 PRD = 2001:2011 11,315,347 Priority year
2 (US OR EP OR GB OR DE OR ES OR
FR OR IT OR NL OR JP OR CN OR KR
OR IN)/PC
20,081,126 Country or patent administration office (the US, the
European Patent Office, the UK, Germany, Spain,
France, Italy, the Netherlands, Japan, China, Korea, and
India)
3 (RABIES OR RABIC OR RABID OR
LYSSA)/TI/AB/EAB
1,317 Keywords related to rabies
4 (A61K-039/205 OR
C07K-014/145)/IC
601 IPC for medical preparations containing antigens or
antibodies against Rhabdoviridae (A61K-039/205) or
peptides with more than 20 amino acids from
Rhabdoviridae (C07K-014/145)
5 (A61P-031/12 OR A61P-031/14)/IC 25,706 IPC for the specific therapeutic activity of chemical
compounds or medicinal preparations for
antiinfectives (A61P-031/12) or RNA viruses
(A61P-031/14)
6 (G01N-033/569)/IC 11,177 IPC for investigating or analyzing materials by
determining the chemical or physical properties of
micro-organisms
7 1 AND 2 AND 3 AND
(4 OR 5 OR 6)
354 Targeted patent applications
IPC: International Patent Classification
*The number of patent applications was calculated by patent family. In some cases, a patent family contains a number
of relevant patent applications.
Table 3. Table 3 Search formula and the number of patent applications retrieved
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applications after 2002. Japan had a downward trend after 2009 and fell behind India during
2009–2010 (Figure 5).
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Figure 5. Number of patent applications related to rabies control by country during 2001–2011
The number of patent applications was calculated by patent family. In some cases, a patent
family contains a number of relevant patent applications. US: United States, CN: China, WO:
PCT, EP: European Patent Office, JP: Japan, IN: India, KR: Korea, DE: Germany, ES: Spain, GB:
UK, FR: France, IT: Italy, NL: the Netherlands
3.4. Number of patent applicants by country
The US had the most applicants, but was overtaken by China in 2008–2009. China had a
remarkable increase in applicants after 2003, while it decreased temporarily in 2006. Germany,
Japan, and France had ≤5 patent applications per year during 2001–2011 (Figure 6).
3.5. Major technological fields of patent applications
The technological types of 237 patent applications related to rabies control were determined
in the contexts of prevention, diagnosis, and treatment. As shown in Table 4, the patent
applications were classified into seven technological fields: recombinant virus, protein,
peptide, organic active ingredient, natural product, fabrication method, and mutant. Patent
applications related to recombinant viruses were the most frequent and they primarily claimed
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uses for the prevention and treatment of rabies. Patent applications related to organic active
ingredients used for treatments, fabrication methods for prevention (primarily vaccines), and
natural products and Chinese herbal extracts for treatment were more frequent than other
patent applications. Patent applications related to natural products and Chinese herbal extracts
were primarily from China.
The number of patent applications was calculated by patent family. In some cases, a patent
belonged to two or more technology fields, so the total number of applications exceeded 237.
3.6. Top 10 most cited patent applications
Table 5 shows the top 10 most cited patent applications related to rabies. All the patent
applications were related to diagnostic or therapeutic methods for rabies, such as immuno‐
conjugates (US 5332567, WO200454622), a vaccine carrier (US 6019978), and a monoclonal
antibody production system (WO200476677). It was interesting that all the patent applications
were applicable to various pathogens, such as bacteria, viruses, and mycoplasma, whereas
none were specifically applicable to the rabies virus.
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Figure 6. Number of patent applicants related to rabies control by country during 2001–2011
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Rank Cited
number
patent number applicants Title Contribution to rabies control
1 101 US5332567 IMMUNOMEDICS Detection and treatment of infections with 
immunoconjugates
Yes (method of targeting a polyspecific diagnostic agent 
for virus infection including rabies)
2 57 WO200366005 CONFORMA 
THERAPEUTICS 
Ansamycins having improved pharmacological and 
biological properties
Yes (method of  treating or preventing infection 
including rabies)
3 45 WO200464759 CHIRON Use of tryptanthrin compounds for immune potentiation Yes (enhancement of the immune response to infections 
including rabies)
4 40 WO200476677 INSTITUTE FOR 
RESEARCH 
BIOMEDICINE 
Monoclonal antibody production by EBV transformation 
of B cells 
Yes (providing a neutralizing monoclonal human 
antibodies that recognizes antigens from  various 
pathogens including rabies virus)
5 37 US20060228300 IBC 
PHARMACEUTICALS 
Stably tethered structures of defined compositions with 
multiple functions or binding specificities
Yes (useful for treating subjects infected with various 
pathogens including rabies virus)
6 32 US6019978 WISTAR INSTITUTE 
OF ANATOMY & 
BIOLOGY
UNIVERSITY OF 
PENNSYLVANIA
Replication-defective adenovirus human type 5 
recombinant as a vaccine carrier
Yes (more efficacious method in comparison with the 
currently used vaccinia rabies vaccine)
7 31 WO9800166 RHONE MERIEUX Recombinant canine adenovirus (CAV) containing 
exogenous DNA 
Yes (vector for cloning heterologous DNA encodes 
epitopes of interests from antigens of veterinary 
pathogens including rabies)
8 31 US6180111 MARYLAND 
UNIVERSITY OF
Vaccine delivery system Yes (useful for the diagnosis of viral diseases including 
rabies)
9 29 WO200775270 IBC 
PHARMACEUTICALS 
Multivalent immunoglobulin-based bioactive assemblies Yes (useful for treating  infection with various 
pathogens including rabies virus)
10 29 WO200454622 IMMUNOMEDICS 
MCCALL JOHN 
DOUGLAS 
Immunoconjugates with an intracellularly-cleavable 
linkage 
Yes (useful for therapeutic conjugates against  
pathogens including rabies virus)
Table 5. Top 10 most cited patent applications related to rabies control during 2001–2011
 
–
Prevention 
(primarily 
vaccine)
Diagnosis 
(detection of 
virus, 
antibodies)
Treatment
(medical drugs 
for post-exposure  
prophylaxis etc.)
Other
Recombinant virus
(e.g. replication-defective adenovirus 
recombinant as a rabies vaccine carrier)
60 12 42 9
Protein (e.g. chimeric rabies G protein ) 18 13 15 0
Peptide (e.g. antigenic peptide of rabies virus) 10 8 14 0
Organic active ingredient (e.g. 
organophosphorous compound for producing 
medicaments for therapeutic treatment of 
infections caused by virus )
17 2 36 0
Natural product,  Chinese herbal extract (e.g. 
red bean-derived antiviral agent)
9 0 24 2
Fabrication method (e.g. preparation method of 
rabies vaccine)
31 7 15 8
Mutant (e.g. attenuated recombinant rabies 
virus mutant for live vaccines)
10 1 5 0
Other 10 14 5 2
Table 4. Technology fields of patent applications related to rabies control during 2001–2011
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4. General overview of research and technology development related to
rabies control based on bibliometric and patent analyses
Our bibliometric and patent analyses using the Web of Science®, DWPI, and DPCI highlighted
five main features of the trends in research and technology development related to rabies
control during 2001–2011.
4.1. Research and technology developments related to rabies control were diverse and
polyspecific
Given that the major research areas were veterinary sciences, virology, and immunology
(Figure 4), and that the two most cited articles related to rabies control belonged to interdis‐
ciplinary research regions, i.e., agent-based modeling and economic analysis (Table 2), it is
apparent that rabies research has diversified from classical to novel research areas. In partic‐
ular, new research is prospective and aims to accelerate the development of domestic and
international management frameworks for rabies.
However, the methods used for rabies diagnosis and vaccine development are progressing if
we take patent US 5332567 and US 6019978 as examples of the top 10 most cited patent
applications (Table 5). These methods were characterized as being applicable to various other
pathogens and were polyspecific. Given that current rabies vaccines aim to introduce new
functions, e.g., animal rabies vaccines combined with other antigens [3], these polyspecific
methods would contribute to further vaccine development.
4.2. Gap between research and technology development for rabies control
We found that the number of articles related to rabies increased throughout the world, but the
number of patent applications directed at rabies control was stable according to PCT and in
each country. Given that only two of the top 10 most cited articles were directly related to
rabies control, as shown in Table 2, and that none of the top 10 patent applications were
specifically for rabies control, as shown in Table 5, it was not clear whether the articles were
directly linked to the patent applications for rabies. Thus, it is not necessarily that research on
rabies leads to technological developments related to rabies control.
4.3. The US, France, and the UK are the leading countries for rabies research
The survey demonstrated that the US led rabies research because it had the highest percentage
of total articles related to rabies, i.e., 32.5% of the total. France ranked second (10.6%) but there
was a big difference compared with the US. These two countries and the UK were also the top
three producers of articles in the area of infectious diseases (Table 1). Four of the top five
organizations that published articles related to rabies were also in these three countries. These
results showed that the US, France, and the UK were the undisputed leaders in research on
rabies and all infectious diseases.
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4.4. Brazil was a particularly productive country for rabies research
Like the US, France, and the UK, Brazil was considered to be a productive country for rabies
research because it published the fourth highest number of articles (Table 1). The Universidade
de Sao Paulo was ranked fourth among the top five organizations (Figure 3) and it played a
leading role in rabies research in Brazil.
Brazil may have a high level of rabies research because this country has initiated nationwide
public campaigns to vaccinate dogs and cats against rabies, which have demanded studies to
assess the antibody levels in vaccinated animals [29]. Moreover, research on rabies control has
been active because the population has a serious risk of infection given the close relationships
between these potential zoonosis-transmitting animals and humans [29].
4.5. Development of patent applications for rabies control in China
China exhibited a remarkable increase in patent applications (Figure 5). It was significant that
China overtook the US with respect to the number of patent applications after 2007. From a
technological perspective, patent applications related to natural products and Chinese herbal
extracts increased greatly, as described in section 3.5.
The Chinese statistics showed that 1,633,000 patent applications (the total number of invention
patents, design patents, and utility models) were filed with the State Intellectual Property
Office (SIPO) by 2011, with a greater than threefold increase during 2005 alone [30]. This
remarkable increase in the overall volume of patent applications in China may be attributable
to the subsidization policy specified by the China Elements of Strategy for Intellectural
Property Right, which facilitated the creation, application, protection, and management of
intellectual property rights in 2008. Thus, the notable increase in overall patent applications
after the change in China’s policy may have led to the increased number of patent applications
related to rabies control.
5. Conclusion
This chapter describes the trends in research and technology development related to rabies
control during 2001–2011, which illustrate the measures introduced to control zoonoses. We
found that the research and technology development activities differed among countries,
which were characterized as diverse and polyspecific. The methods used for rabies diagnosis
and vaccine development were found to be progressing.
The highly cited research on agent-based modeling and economic impact analysis shows that
new interdisciplinary studies of rabies are being conducted. These studies are aimed to
accelerate the development of domestic and international management frameworks for rabies.
This bibliometric and patent analysis did not demonstrate that articles (indicators of research
outputs) were closely linked to patent applications (indicators of technology development).
Our method aimed to measure science linkage to analyze the effects of science and research
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on technology development. Science linkage is an indicator of technological innovation, which
is based on calculating the number of non-patent references such as articles, which are an
indicator of the degree of science related to patents, i.e., the number of articles cited per patent
[31]. There are technological limitations to science linkage, but many studies have aimed to
measure the linkage of patents filed in the US and Europe [31]. From this perspective, meas‐
uring science linkage may be a challenge during future surveys of the trends in research and
technology development related to rabies control. This challenge will also apply to zoonoses
in general.
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